{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:32:11Z","timestamp":1794864731745,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-60013-y","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T08:35:54Z","timestamp":1748075754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["HSK21542 in patients with postoperative pain: two phase 3, multicentre, double-blind, randomized, controlled trials"],"prefix":"10.1038","volume":"16","author":[{"given":"Yinbo","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengfeng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guonian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1355-1261","authenticated-orcid":false,"given":"Min","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"key":"60013_CR1","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1213\/01.ANE.0000068822.10113.9E","volume":"97","author":"JL Apfelbaum","year":"2003","unstructured":"Apfelbaum, J. L., Chen, C., Mehta, S. S. & Gan, T. J. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth. Analg. 97, 534\u2013540 (2003).","journal-title":"Anesth. Analg."},{"key":"60013_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jpain.2015.12.008","volume":"17","author":"R Chou","year":"2016","unstructured":"Chou, R. et al. Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists\u2019 Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J. Pain 17, 131\u2013157 (2016).","journal-title":"J. Pain"},{"key":"60013_CR3","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3390\/curroncol30010065","volume":"30","author":"J Qiu","year":"2023","unstructured":"Qiu, J. et al. Pain incidence and associated risk factors among cancer patients within 72 hours after surgery: a large retrospective analysis. Curr. Oncol. 30, 854\u2013864 (2023).","journal-title":"Curr. Oncol."},{"key":"60013_CR4","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/S0140-6736(06)68700-X","volume":"367","author":"H Kehlet","year":"2006","unstructured":"Kehlet, H., Jensen, T. S. & Woolf, C. J. Persistent postsurgical pain: risk factors and prevention. Lancet 367, 1618\u20131625 (2006).","journal-title":"Lancet"},{"key":"60013_CR5","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/S0140-6736(19)30352-6","volume":"393","author":"P Glare","year":"2019","unstructured":"Glare, P., Aubrey, K. R. & Myles, P. S. Transition from acute to chronic pain after surgery. Lancet 393, 1537\u20131546 (2019).","journal-title":"Lancet"},{"key":"60013_CR6","doi-asserted-by":"publisher","unstructured":"Liu, Y. et al. Postoperative pain-related outcomes and perioperative pain management in China: a population-based study. Lancet Reg. Health West. Pac. https:\/\/doi.org\/10.1016\/j.lanwpc.2023.100822 (2023).","DOI":"10.1016\/j.lanwpc.2023.100822"},{"key":"60013_CR7","doi-asserted-by":"crossref","unstructured":"Mehari, E. E., Bizuneh, Y. B., Fentie, D. Y. & Arefayne, N. R. Prevalence and factors associated with acute postoperative pain after emergency abdominal surgery. Open Pain J. 15, e187638632208250 (2022).","DOI":"10.2174\/18763863-v15-e2208250"},{"key":"60013_CR8","doi-asserted-by":"publisher","first-page":"737","DOI":"10.4103\/0019-5049.191686","volume":"60","author":"PK Singh","year":"2016","unstructured":"Singh, P. K., Saikia, P. & Lahakar, M. Prevalence of acute post-operative pain in patients in adult age-group undergoing inpatient abdominal surgery and correlation of intensity of pain and satisfaction with analgesic management: a cross-sectional single institute-based study. Indian J. Anaesth. 60, 737\u2013743 (2016).","journal-title":"Indian J. Anaesth."},{"key":"60013_CR9","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","volume":"115","author":"R Al-Hasani","year":"2011","unstructured":"Al-Hasani, R. & Bruchas, M. R. Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology 115, 1363\u20131381 (2011).","journal-title":"Anesthesiology"},{"key":"60013_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0301-0082(02)00008-4","volume":"66","author":"BL Kieffer","year":"2002","unstructured":"Kieffer, B. L. & Gaveriaux-Ruff, C. Exploring the opioid system by gene knockout. Prog. Neurobiol. 66, 285\u2013306 (2002).","journal-title":"Prog. Neurobiol."},{"key":"60013_CR11","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1124\/pr.110.003145","volume":"63","author":"C Stein","year":"2011","unstructured":"Stein, C. & Machelska, H. Modulation of peripheral sensory neurons by the immune system: implications for pain therapy. Pharm. Rev. 63, 860\u2013881 (2011).","journal-title":"Pharm. Rev."},{"key":"60013_CR12","first-page":"1065","volume":"118","author":"C Zollner","year":"2008","unstructured":"Zollner, C. et al. Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain. J. Clin. Invest. 118, 1065\u20131073 (2008).","journal-title":"J. Clin. Invest."},{"key":"60013_CR13","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/j.1526-4637.2012.01438.x","volume":"13","author":"DF Martins","year":"2012","unstructured":"Martins, D. F. et al. Ankle joint mobilization decreases hypersensitivity by activation of peripheral opioid receptors in a mouse model of postoperative pain. Pain Med. 13, 1049\u20131058 (2012).","journal-title":"Pain Med"},{"key":"60013_CR14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.pain.2010.09.009","volume":"151","author":"CL Schramm","year":"2010","unstructured":"Schramm, C. L. & Honda, C. N. Co-administration of delta- and mu-opioid receptor agonists promotes peripheral opioid receptor function. Pain 151, 763\u2013770 (2010).","journal-title":"Pain"},{"key":"60013_CR15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/978-3-662-44605-8_16","volume":"226","author":"A Cowan","year":"2015","unstructured":"Cowan, A., Kehner, G. B. & Inan, S. Targeting itch with ligands selective for kappa opioid receptors. Handb. Exp. Pharm. 226, 291\u2013314 (2015).","journal-title":"Handb. Exp. Pharm."},{"key":"60013_CR16","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1097\/AJP.0b013e3181c49e3a","volume":"26","author":"TW Vanderah","year":"2010","unstructured":"Vanderah, T. W. Delta and kappa opioid receptors as suitable drug targets for pain. Clin. J. Pain 26, S10\u2013S15 (2010).","journal-title":"Clin. J. Pain"},{"key":"60013_CR17","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.neuron.2018.08.044","volume":"99","author":"LM Snyder","year":"2018","unstructured":"Snyder, L. M. et al. Kappa opioid receptor distribution and function in primary afferents. Neuron 99, 1274\u20131288.e1276 (2018).","journal-title":"Neuron"},{"key":"60013_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.coph.2004.08.012","volume":"5","author":"CP Bailey","year":"2005","unstructured":"Bailey, C. P. & Connor, M. Opioids: cellular mechanisms of tolerance and physical dependence. Curr. Opin. Pharm. 5, 60\u201368 (2005).","journal-title":"Curr. Opin. Pharm."},{"key":"60013_CR19","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1111\/bph.13809","volume":"175","author":"T Gunther","year":"2018","unstructured":"Gunther, T. et al. Targeting multiple opioid receptors - improved analgesics with reduced side effects?. Br. J. Pharm. 175, 2857\u20132868 (2018).","journal-title":"Br. J. Pharm."},{"key":"60013_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/02791072.2017.1295334","volume":"49","author":"DE Smith","year":"2017","unstructured":"Smith, D. E. Medicalizing the opioid epidemic in the U.S. in the era of health care reform. J. Psychoact. Drugs 49, 95\u2013101 (2017).","journal-title":"J. Psychoact. Drugs"},{"key":"60013_CR21","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1124\/jpet.120.000134","volume":"375","author":"KF Paton","year":"2020","unstructured":"Paton, K. F., Atigari, D. V., Kaska, S., Prisinzano, T. & Kivell, B. M. Strategies for developing kappa opioid receptor agonists for the treatment of pain with fewer side effects. J. Pharm. Exp. Ther. 375, 332\u2013348 (2020).","journal-title":"J. Pharm. Exp. Ther."},{"key":"60013_CR22","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1213\/00000539-198305000-00005","volume":"62","author":"E Freye","year":"1983","unstructured":"Freye, E., Hartung, E. & Schenk, G. K. Bremazocine: an opiate that induces sedation and analgesia without respiratory depression. Anesth. Analg. 62, 483\u2013488 (1983).","journal-title":"Anesth. Analg."},{"key":"60013_CR23","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1111\/cts.13042","volume":"14","author":"ER Viscusi","year":"2021","unstructured":"Viscusi, E. R. et al. Effect of difelikefalin, a selective kappa opioid receptor agonist, on respiratory depression: a randomized, double-blind, placebo-controlled trial. Clin. Transl. Sci. 14, 1886\u20131893 (2021).","journal-title":"Clin. Transl. Sci."},{"key":"60013_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.773204","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Antinociceptive and antipruritic effects of HSK21542, a peripherally-restricted kappa opioid receptor agonist, in animal models of pain and itch. Front. Pharm. 12, 773204 (2021).","journal-title":"Front. Pharm."},{"key":"60013_CR25","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2174\/1381612043453036","volume":"10","author":"DL DeHaven-Hudkins","year":"2004","unstructured":"DeHaven-Hudkins, D. L. & Dolle, R. E. Peripherally restricted opioid agonists as novel analgesic agents. Curr. Pharm. Des. 10, 743\u2013757 (2004).","journal-title":"Curr. Pharm. Des."},{"key":"60013_CR26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fpsyt.2014.00170","volume":"5","author":"L Lalanne","year":"2014","unstructured":"Lalanne, L., Ayranci, G., Kieffer, B. L. & Lutz, P. E. The kappa opioid receptor: from addiction to depression, and back. Front. Psychiatry 5, 170 (2014).","journal-title":"Front. Psychiatry"},{"key":"60013_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.tins.2012.11.002","volume":"36","author":"PE Lutz","year":"2013","unstructured":"Lutz, P. E. & Kieffer, B. L. Opioid receptors: distinct roles in mood disorders. Trends Neurosci. 36, 195\u2013206 (2013).","journal-title":"Trends Neurosci."},{"key":"60013_CR28","doi-asserted-by":"publisher","first-page":"9937","DOI":"10.1523\/JNEUROSCI.0953-16.2016","volume":"36","author":"SK Nygard","year":"2016","unstructured":"Nygard, S. K., Hourguettes, N. J., Sobczak, G. G., Carlezon, W. A. & Bruchas, M. R. Stress-induced reinstatement of nicotine preference requires dynorphin\/kappa opioid activity in the basolateral amygdala. J. Neurosci. 36, 9937\u20139948 (2016).","journal-title":"J. Neurosci."},{"key":"60013_CR29","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.pharmthera.2007.06.011","volume":"116","author":"TS Shippenberg","year":"2007","unstructured":"Shippenberg, T. S., Zapata, A. & Chefer, V. I. Dynorphin and the pathophysiology of drug addiction. Pharm. Ther. 116, 306\u2013321 (2007).","journal-title":"Pharm. Ther."},{"key":"60013_CR30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00213-004-2087-0","volume":"179","author":"Y Zhang","year":"2005","unstructured":"Zhang, Y., Butelman, E. R., Schlussman, S. D., Ho, A. & Kreek, M. J. Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors. Psychopharmacology 179, 551\u2013558 (2005).","journal-title":"Psychopharmacology"},{"key":"60013_CR31","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S0022-3565(24)34907-9","volume":"290","author":"H Machelska","year":"1999","unstructured":"Machelska, H. et al. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans. J. Pharm. Exp. Ther. 290, 354\u2013361 (1999).","journal-title":"J. Pharm. Exp. Ther."},{"key":"60013_CR32","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/j.1476-5381.1989.tb11911.x","volume":"96","author":"JS Shaw","year":"1989","unstructured":"Shaw, J. S., Carroll, J. A., Alcock, P. & Main, B. G. ICI 204448: a kappa-opioid agonist with limited access to the CNS. Br. J. Pharm. 96, 986\u2013992 (1989).","journal-title":"Br. J. Pharm."},{"key":"60013_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejphar.2008.01.011","volume":"583","author":"TW Vanderah","year":"2008","unstructured":"Vanderah, T. W. et al. Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors. Eur. J. Pharm. 583, 62\u201372 (2008).","journal-title":"Eur. J. Pharm."},{"key":"60013_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2024.105731","volume":"154","author":"X Gou","year":"2024","unstructured":"Gou, X. et al. Preclinical evaluation of abuse potential of the peripherally-restricted kappa opioid receptor agonist HSK21542. Regul. Toxicol. Pharm. 154, 105731 (2024).","journal-title":"Regul. Toxicol. Pharm."},{"key":"60013_CR35","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1016\/j.jpain.2015.01.341","volume":"16","author":"F Menzaghi","year":"2015","unstructured":"Menzaghi, F., Spencer, R., Abrouk, N., Lewis, M. & Chalmers, D. 422) CR845, a peripheral kappa opioid, provides better pain relief with less nausea and vomiting than placebo in patients after bunionectomy. J. Pain 16, S81 (2015).","journal-title":"J. Pain"},{"key":"60013_CR36","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1016\/j.jpain.2015.01.340","volume":"16","author":"L Webster","year":"2015","unstructured":"Webster, L., Menzaghi, F. & Spencer, R. 421) CR845, a novel peripherally-acting kappa opioid receptor agonist, has low abuse potential compared with pentazocine. J. Pain 16, S81 (2015).","journal-title":"J. Pain"},{"key":"60013_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1203642","volume":"14","author":"M Pan","year":"2023","unstructured":"Pan, M. et al. Safety and effectiveness of HSK21542 for hemodialysis patients: a multiple ascending dose study. Front. Pharm. 14, 1203642 (2023).","journal-title":"Front. Pharm."},{"key":"60013_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/17512433.2025.2449983","volume":"18","author":"K Wang","year":"2025","unstructured":"Wang, K. et al. Population pharmacokinetic modeling and exposure-response analysis of anrikefon: insights and implications in clinical analgesia. Expert Rev. Clin. Pharm. 18, 77\u201388 (2025).","journal-title":"Expert Rev. Clin. Pharm."},{"key":"60013_CR39","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa2209870","volume":"389","author":"J Jones","year":"2023","unstructured":"Jones, J. et al. Selective inhibition of Na(V)1.8 with VX-548 for acute pain. N. Engl. J. Med. 389, 393\u2013405 (2023).","journal-title":"N. Engl. J. Med."},{"key":"60013_CR40","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.2147\/JPR.S137952","volume":"10","author":"N Singla","year":"2017","unstructured":"Singla, N. et al. A randomized, phase IIb study investigating oliceridine (TRV130), a novel micro-receptor G-protein pathway selective (mu-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty. J. Pain Res. 10, 2413\u20132424 (2017).","journal-title":"J. Pain Res."},{"key":"60013_CR41","doi-asserted-by":"publisher","first-page":"e1846","DOI":"10.1097\/GOX.0000000000001846","volume":"6","author":"N Singla","year":"2018","unstructured":"Singla, N. et al. Efficacy and safety of intravenous meloxicam in subjects with moderate-to-severe pain following abdominoplasty. Plast. Reconstr. Surg. Glob. Open 6, e1846 (2018).","journal-title":"Plast. Reconstr. Surg. Glob. Open"},{"key":"60013_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.837671","volume":"13","author":"ML Dalefield","year":"2022","unstructured":"Dalefield, M. L., Scouller, B., Bibi, R. & Kivell, B. M. The kappa opioid receptor: a promising therapeutic target for multiple pathologies. Front. Pharm. 13, 837671 (2022).","journal-title":"Front. Pharm."},{"key":"60013_CR43","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1056\/NEJMoa1912770","volume":"382","author":"S Fishbane","year":"2020","unstructured":"Fishbane, S. et al. A phase 3 trial of difelikefalin in hemodialysis patients with pruritus. N. Engl. J. Med. 382, 222\u2013232 (2020).","journal-title":"N. Engl. J. Med."},{"key":"60013_CR44","doi-asserted-by":"crossref","unstructured":"Wala, K. & Szepietowski, J. C. Difelikefalin in the treatment of chronic kidney disease-associated pruritus: a systematic review. Pharmaceuticals. 15, 934 (2022).","DOI":"10.3390\/ph15080934"},{"key":"60013_CR45","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s40265-021-01619-6","volume":"81","author":"ED Deeks","year":"2021","unstructured":"Deeks, E. D. Difelikefalin: first approval. Drugs 81, 1937\u20131944 (2021).","journal-title":"Drugs"},{"key":"60013_CR46","first-page":"S97","volume":"127","author":"J Stauffer","year":"2015","unstructured":"Stauffer, J., Spencer, R. & Menzaghi, F. Analgesic efficacy of the peripheral kappa-opioid agonist CR845 in laparoscopic hysterectomy. Postgrad. Med. 127, S97 (2015).","journal-title":"Postgrad. Med."},{"key":"60013_CR47","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s13318-023-00858-0","volume":"48","author":"JJ Yuan","year":"2023","unstructured":"Yuan, J. J. et al. Pharmacokinetics, mass balance and metabolism of [(14)C]HSK21542, a novel Kappa opioid receptor agonist, in humans. Eur. J. Drug Metab. Pharmacokinet. 48, 723\u2013731 (2023).","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"60013_CR48","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/bcpt.14094","volume":"135","author":"R Shao","year":"2024","unstructured":"Shao, R. et al. Phase I clinical trial evaluating the safety, tolerance, pharmacokinetics and pharmacodynamics of HSK21542 injection in healthy volunteers. Basic Clin. Pharm. Toxicol. 135, 743\u2013754 (2024).","journal-title":"Basic Clin. Pharm. Toxicol."},{"key":"60013_CR49","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1213\/ANE.0000000000004833","volume":"131","author":"TJ Gan","year":"2020","unstructured":"Gan, T. J. et al. Fourth consensus guidelines for the management of postoperative nausea and vomiting. Anesth. Analg. 131, 411\u2013448 (2020).","journal-title":"Anesth. Analg."},{"key":"60013_CR50","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/bja\/aeu449","volume":"114","author":"S Achuthan","year":"2015","unstructured":"Achuthan, S. et al. Gabapentin prophylaxis for postoperative nausea and vomiting in abdominal surgeries: a quantitative analysis of evidence from randomized controlled clinical trials. Br. J. Anaesth. 114, 588\u2013597 (2015).","journal-title":"Br. J. Anaesth."},{"key":"60013_CR51","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1007\/BF03016875","volume":"49","author":"M Elhakim","year":"2002","unstructured":"Elhakim, M., Nafie, M., Mahmoud, K. & Atef, A. Dexamethasone 8 mg in combination with ondansetron 4 mg appears to be the optimal dose for the prevention of nausea and vomiting after laparoscopic cholecystectomy. Can. J. Anaesth. 49, 922\u2013926 (2002).","journal-title":"Can. J. Anaesth."},{"key":"60013_CR52","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0002-9610(00)00574-2","volume":"181","author":"EB Wilson","year":"2001","unstructured":"Wilson, E. B., Bass, C. S., Abrameit, W., Roberson, R. & Smith, R. W. Metoclopramide versus ondansetron in prophylaxis of nausea and vomiting for laparoscopic cholecystectomy. Am. J. Surg. 181, 138\u2013141 (2001).","journal-title":"Am. J. Surg."},{"key":"60013_CR53","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1365-2982.1990.tb00033.x","volume":"2","author":"M Gu\u00e9","year":"1990","unstructured":"Gu\u00e9, M., Junien, J. L., Pascaud, X. & Bu\u00e9no, L. Antagonism of stress-induced gastric motor alteration and plasma cortisol release by fedotozine (JO 1196) in dogs. Neurogastroenterol. Motil. 2, 258\u2013264 (1990).","journal-title":"Neurogastroenterol. Motil."},{"key":"60013_CR54","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.2147\/JPR.S251175","volume":"13","author":"H Minkowitz","year":"2020","unstructured":"Minkowitz, H. et al. IV tramadol - a new treatment option for management of post-operative pain in the US: an open-label, single-arm, safety trial including various types of surgery. J. Pain Res. 13, 1155\u20131162 (2020).","journal-title":"J. Pain Res."},{"key":"60013_CR55","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2165\/00003088-200443130-00004","volume":"43","author":"S Grond","year":"2004","unstructured":"Grond, S. & Sablotzki, A. Clinical pharmacology of tramadol. Clin. Pharmacokinet. 43, 879\u2013923 (2004).","journal-title":"Clin. Pharmacokinet."},{"key":"60013_CR56","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/s41586-024-07816-z","volume":"632","author":"C Chen","year":"2024","unstructured":"Chen, C. et al. Neural circuit basis of placebo pain relief. Nature 632, 1092\u20131100 (2024).","journal-title":"Nature"},{"key":"60013_CR57","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1016\/j.bja.2019.01.040","volume":"123","author":"L Vase","year":"2019","unstructured":"Vase, L. & Wartolowska, K. Pain, placebo, and test of treatment efficacy: a narrative review. Br. J. Anaesth. 123, e254\u2013e262 (2019).","journal-title":"Br. J. Anaesth."},{"key":"60013_CR58","unstructured":"EMA\/CHMP. Guidelines on the clinical development of medicinal products intended for the treatment of pain. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-guideline-clinical-development-medicinal-products-intended-treatment-pain-second-draft_en.pdf (2016)."},{"key":"60013_CR59","unstructured":"U.S. Department of Health and Human Services, F. a. D. A., Center for Drug Evaluation and Research (CDER). Development of nonopioid analgesics for acute pain. https:\/\/www.fda.gov\/media\/156063\/download (2022)."},{"key":"60013_CR60","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s40268-020-00309-0","volume":"20","author":"H Minkowitz","year":"2020","unstructured":"Minkowitz, H. et al. Intravenous tramadol is effective in the management of postoperative pain following abdominoplasty: a three-arm randomized placebo- and active-controlled trial. Drugs R. D. 20, 225\u2013236 (2020).","journal-title":"Drugs R. D."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60013-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60013-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60013-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T10:04:05Z","timestamp":1748081045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60013-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["60013"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-60013-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,24]]},"assertion":[{"value":"19 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4830"}}